Infection Control Archives - Page 3 of 4 - Oncology Nurse Advisor

Infection Control

Mathematical model may reduce infections from chemotherapy

A new mathematical model suggests that proper risk assessment for the risk of infection with cancer chemotherapy needs to evaluate both the quantity and quality of white blood cells. The model was built by Weizmann Institute mathematicians in collaboration with physicians from the Meir Medical Center in Kfar Saba and from the Hoffman-La Roche research center in Basel, Switzerland.

Managing viral infections in severely immunocompromised patients

Oncology nurses play a vital role in patient care, including assessment, early recognition of infections, and patient and family education. Providing evidence-based care and education to severely immunocompromised patients requires knowledge about the association between viruses and diseases, the rationale of specific diagnostic tests, and current treatments.

Oncology FBI team helps promote a culture of safety

Monitoring infection rates and introducing interventions to eliminate central line-associated bloodstream infections (CLABSIs), a serious safety concern for hospitalized oncology patients, is one way nursing care can be advanced in complex health care environments that support a culture of safety, according to a presentation at the Oncology Nursing Society 36th Annual Congress.

Changing practice behaviors reduces central line-associated bloodstream infections

The effects of cancer treatment place patients at high risk for central line-associated blood stream infections (CLABSIs), which directly reflect the care provided at the time of insertion and through the lifetime of the central line. These infections are a significant cause of morbidity, mortality, and increased health care costs. These are the findings of a study presented at the Oncology Nursing Society 36th Annual Congress.

Interventions decrease incidence of catheter-related bloodstream infections

An educational intervention designed to reduce catheter-related bloodstream infections (CR-BSIs) resulted in decreased infection rates that were sustained over time, results of a quality improvement process measuring the efficacy of such interventions have shown. Incidence of CR-BSIs in hematology and oncology inpatients are a high-priority concern: severe sepsis related to these infections can result in increased costs, morbidity and mortality, and prolonged hospitalization. The data were presented at the Oncology Nursing Society 36th Annual Congress.

Next post in ONS Annual Congress 2011